ChemoCentryx - Ownership and Business Overview

Life ScienceCompany

ChemoCentryx Ownership

Who owns ChemoCentryx?

ChemoCentryx is owned by Amgen. It was acquired on August 4, 2022.

ChemoCentryx Business Overview

Where is ChemoCentryx headquartered?

ChemoCentryx is headquartered in San Carlos, California.

What is ChemoCentryx’s revenue?

ChemoCentryx disclosed revenue of 32M USD for 2021 and 64M USD for 2020.

What sector is ChemoCentryx in?

ChemoCentryx is a life science company.

When was ChemoCentryx founded?

ChemoCentryx was founded in 1996.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 291 acquisitions of life science companies in 2022, including 36 acquisitions by private equity firms, and 255 by strategics.

ChemoCentryx

ChemoCentryx, Inc.

835 Industrial Avenue Suite 600,
San Carlos, California 94070
United States,
(650) 210 2900
www.chemocentryx.com

ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally administered therapies. ChemoCentryx was incorporated in 1996 and is headquartered in San Carlos, California.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.